Antibody treatment increases M2 microglia and reduces brain injury and inflammatory response after experimental intracerebral hemorrhage
Updated time: 2023-05-08 13:52:17
Antibody treatment increases M2 microglia and reduces brain injury and inflammatory response after experimental intracerebral hemorrhage
Docket Number
12A-1080315
Announcement Date
2020-05-20
IP Status
US 11097134 B2、TW I798552
Abstract
This invention uses a specific antibody to reduce brain damage after intracerebral hemorrhage (ICH). Effect of antibody:
- Inhibit inflammation, reduces brain damage and suppress the activation of microglia and macrophages
- Decrease M1 while increase M2 macrophages and microglia.
- Inhibit cytokine or thrombin induced inflammatory response.
- Reduce neuron death and brain atrophy after ICH.
Antibody can be applied by intracerebroventricle (icv) injection to injury area or by intravenous injection after ICH.
Technological Advantages
- Antibody can be delivered by icv or iv injection to have protective effects
- Antibody modulate phenotype of macrophages and microglia from M1 (proinflammatory) to M2 (anti-inflammatory and protective)
- Delayed antibody injection, 3 hours after ICH, has protective effect
- No effective medical treatment available for ICH therapy
Applications of Technology
- To reduce brain injury and improve functional recovery after intracerebral hemorrhage
- To suppress brain inflammation after brain injury
- To module polarization of macrophages and microglia from M1 to M2 phenotypes
Inventor
Shyue, Song-Kun
Contact person
If you are interested in this technology, please fill in the information on the webpage under the manufacturer option (Request for Technology Licensing, Material Transfer, or Sponsored Research) on the website of this office

Antibody treatment increases M2 microglia and reduces brain injury and inflammatory response after experimental intracerebral hemorrhage